Abstract Details

Title Pharmacokinetics of Oral Teriflunomide, a Novel Oral Disease-Modifying Agent under Investigation for the Treatment of Multiple Sclerosis

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 032

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Françoise Menguy-Vacheron, PhD (Sanofi-Aventis)	No disclosure on file
	No disclosure on file
Mohammad Moussavi, MD	Dr. Moussavi has nothing to disclose.

��ɫ��